Pinebridge Investments L.P. Takes $77,000 Position in Cryoport, Inc. (NASDAQ:CYRX)

Pinebridge Investments L.P. purchased a new stake in Cryoport, Inc. (NASDAQ:CYRX – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,300 shares of the consumer goods maker’s stock, valued at approximately $77,000.

Several other hedge funds also recently bought and sold shares of the company. Citigroup Inc. lifted its stake in shares of Cryoport by 108.9% in the 4th quarter. Citigroup Inc. now owns 11,038 shares of the consumer goods maker’s stock valued at $653,000 after purchasing an additional 5,754 shares during the period. Teacher Retirement System of Texas lifted its stake in shares of Cryoport by 26.7% in the 4th quarter. Teacher Retirement System of Texas now owns 7,230 shares of the consumer goods maker’s stock valued at $428,000 after purchasing an additional 1,523 shares during the period. Granite Investment Partners LLC increased its position in shares of Cryoport by 4.9% in the 4th quarter. Granite Investment Partners LLC now owns 1,161,918 shares of the consumer goods maker’s stock valued at $68,751,000 after buying an additional 54,652 shares in the last quarter. HighTower Advisors LLC bought a new stake in shares of Cryoport in the 4th quarter valued at $381,000. Finally, BNP Paribas Arbitrage SA increased its position in shares of Cryoport by 10.3% in the 4th quarter. BNP Paribas Arbitrage SA now owns 8,650 shares of the consumer goods maker’s stock valued at $512,000 after buying an additional 808 shares in the last quarter.

In other news, CFO Robert Stefanovich sold 1,095 shares of the firm’s stock in a transaction dated Wednesday, March 9th. The stock was sold at an average price of $31.05, for a total value of $33,999.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jerrell Shelton sold 3,298 shares of the firm’s stock in a transaction dated Wednesday, March 9th. The shares were sold at an average price of $31.05, for a total value of $102,402.90. The disclosure for this sale can be found here. Insiders sold a total of 5,803 shares of company stock valued at $180,183 in the last 90 days. 9.70% of the stock is owned by corporate insiders.

A number of analysts recently commented on CYRX shares. B. Riley lowered their price objective on shares of Cryoport from $61.00 to $55.00 in a research report on Tuesday. KeyCorp lowered their price objective on shares of Cryoport from $92.00 to $52.00 in a research report on Friday, May 6th. Needham & Company LLC restated a “buy” rating and issued a $45.00 price objective on shares of Cryoport in a research report on Wednesday, April 13th. SVB Leerink upped their price objective on shares of Cryoport from $75.00 to $92.00 and gave the company an “outperform” rating in a research report on Friday, February 25th. Finally, Roth Capital lowered their target price on Cryoport from $90.00 to $67.00 in a report on Tuesday, May 3rd. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Cryoport has a consensus rating of “Buy” and an average price target of $59.00.

CYRX stock opened at $23.02 on Thursday. The stock has a 50-day moving average price of $28.77 and a two-hundred day moving average price of $44.68. The company has a current ratio of 14.98, a quick ratio of 14.48 and a debt-to-equity ratio of 0.68. Cryoport, Inc. has a 1 year low of $19.82 and a 1 year high of $86.30.

Cryoport (NASDAQ:CYRX – Get Rating) last announced its quarterly earnings data on Thursday, May 5th. The consumer goods maker reported ($0.31) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.13). The company had revenue of $52.30 million during the quarter, compared to the consensus estimate of $52.86 million. Cryoport had a negative net margin of 128.78% and a negative return on equity of 13.79%. Cryoport’s revenue was down 1.9% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.13) EPS. As a group, equities research analysts forecast that Cryoport, Inc. will post -0.63 earnings per share for the current fiscal year.

Cryoport Company Profile (Get Rating)

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.

Featured Articles